marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Aldeyra Therapeutics Cash Flow 2011-2024 | ALDX
Annual Cash Flow Aldeyra Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-30.3 M | -56.6 M | -42.6 M | -37.5 M | -45 M | -29.9 M | -19.2 M | - | - | - | - | - | - |
Depreciation & Amortization |
263 K | 259 K | 264 K | 56.2 K | 96.3 K | 71 K | 37.8 K | 35.8 K | 18.8 K | 1.07 K | - | - | - |
Accounts Payables |
1.34 M | 134 K | 1.02 M | 382 K | 808 K | 3.05 M | 1 M | 275 K | 851 K | 341 K | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Aldeyra Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -9.97 M | - | - | - | -9.44 M | - | -45.4 M | - | -12.9 M | - | -31 M | - | -13.5 M | - | -29.2 M | -22.9 M | -15.4 M | - | -33.8 M | -25.4 M | -12.6 M | - | -21.9 M | -14.2 M | -7.95 M | - | -14.2 M | -9.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 60.6 K | - | - | - | 67 K | - | 192 K | - | 62.7 K | - | 203 K | - | 67.9 K | - | 218 K | 145 K | 72 K | - | 72.3 K | 48.3 K | 24.2 K | - | 48.2 K | 29.3 K | 11.4 K | - | 29.9 K | 20 K | 9.66 K | - | 26.5 K | 17.1 K | 8.1 K | - | 10.6 K | 4 K | 1.25 K | - | 339 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
187 K | 254 K | 280 K | 1.34 M | 247 K | 271 K | 430 K | 134 K | 1.31 M | - | 2.44 M | 1.02 M | 468 K | 1.09 M | 449 K | 382 K | 382 K | 382 K | 382 K | 808 K | 808 K | 808 K | 808 K | 3.05 M | 3.05 M | 3.05 M | 3.05 M | 1 M | 1 M | 1 M | 1 M | 275 K | 275 K | 275 K | 275 K | 851 K | 851 K | 851 K | 851 K | 341 K | 341 K | 341 K | 341 K | 342 K | 342 K | 342 K | 342 K | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency